The Motley Fool

2 fast-growth UK shares for my Stocks and Shares ISA in April

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Woman sneaker shoe and Arrow on street with copy space background
Image source: Getty Images

The Stocks and Shares ISA limit will be reset on 6 April 2021. For UK investors that means another £20,000 of tax-free investing room. So I’ve got my eye on two top UK shares for my best possible chance at tax-free gains in 2021.

The brilliant thing about investing in a Stocks and Shares ISA is that all of my capital gains and dividends are free from tax. If I was to buy these shares outside of a Stocks and Shares ISA, I could be forced to pay tax when I come to sell. There is a tax-free allowance of £12,300 for capital gains. But if my investments are above this limit, then I’d have to pay tax.

One Killer Stock For The Cybersecurity Surge

Cybersecurity is surging, with experts predicting that the cybersecurity market will reach US$366 billion by 2028more than double what it is today!

And with that kind of growth, this North American company stands to be the biggest winner.

Because their patented “self-repairing” technology is changing the cybersecurity landscape as we know it…

We think it has the potential to become the next famous tech success story. In fact, we think it could become as big… or even BIGGER than Shopify.

Click here to see how you can uncover the name of this North American stock that’s taking over Silicon Valley, one device at a time…

So to my two top UK shares for April 2021.

Open Orphan

Open Orphan (LSE:ORPH) is a popular healthcare stock: not a biotech but a pharmaceutical services business. That means it doesn’t engage in the risky and costly R&D of drug development. Instead it provides all the background data management and clinical trial services for vaccine and antiviral giants worldwide. Its clients include the likes of Pfizer and Johnson & Johnson.

It is most famous for helping to run the world’s first Covid-19 human challenge trials, winning a £46m UK government contract in October 2020. It also plans to spin off at least four major assets into separate companies. These include selling its novel disease data platform Disease in Motion to wearables giants like Google and Fitbit. Because I already own ORPH, I’ll get shares in each of these new companies in my Stocks and Shares ISA when that happens.

Because it is listed on AIM, it’s a relatively riskier buy than a company on the FTSE 250 or FTSE 100. Companies on this market have less stringent financial reporting requirements than on the higher tier. 

Executive Chair Cathal Friel recently put a $1bn (£720m) valuation target on Open Orphan. That would give the business a share price of around £1.10, 266% higher than today’s 30p price.

Fonix Mobile

The next share I’d like to buy for my Stocks and Shares ISA in April is Fonix Mobile (LSE:FNX). This £160m market cap business focuses on mobile payments and mobile messaging. It has some very big blue-chip names as clients, including ITV, Channel 5, and Bauer Media.

It’s a relatively recent float on AIM, which does present risks. Companies only a few months from their IPO date can rise quickly on buzz and hype alone.

Digging back through Fonix Mobile’s financial statements before it went public, I can see that the company had already produced tens of millions in revenue. Profit before tax was up 49% in 2017 and 83% in 2018. And in its most recent full year to June 2020, revenues were up 29% to £40m with profits 53% higher at £7.1m. I can see that it produced a 260% return on equity and a 286% return on capital. So I know that Fonix Mobile is using its cash extremely well to grow. 

In its half-year report to 31 December 2020 CEO Rob Weisz noted that Fonix would also pay its first-ever dividend. It’s not huge, at 1.7p per share. But given the company’s stonking growth? I can see Fonix Mobile chucking off cash for shareholders for years to come. 

One Killer Stock For The Cybersecurity Surge

Cybersecurity is surging, with experts predicting that the cybersecurity market will reach US$366 billion by 2028more than double what it is today!

And with that kind of growth, this North American company stands to be the biggest winner.

Because their patented “self-repairing” technology is changing the cybersecurity landscape as we know it…

We think it has the potential to become the next famous tech success story.

In fact, we think it could become as big… or even BIGGER than Shopify.

Click here to see how you can uncover the name of this North American stock that’s taking over Silicon Valley, one device at a time…

TomRodgers owns shares of Open Orphan plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.